We performed an integrated genomic and molecular analysis to define the expression of OGN in meningiomas, illustrate how OGN may contribute to meningioma cell growth through interaction with other drivers of meningioma formation such as NF2, AKT, and mTOR, and explore possible therapeutic approaches for OGN-expressing meningiomas. This evidence concerns the gene MTOR and meningioma.